Incyte Corporation (INCY) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Incyte Corporation

NASDAQ | INCY

62.46

USD

+0.13 (+0.21%)

AT CLOSE (AS OF Apr 3, 2025)

$12B

MARKET CAP

415.53

P/E Ratio

0.15

EPS

$84

52 Week High

$50

52 Week Low

TRADE & SERVICES

Sector

INCY Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

INCY Technicals

Tags:

INCY Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$3.9B
Total Revenue	$4.2B
Cost Of Revenue	$312M
Costof Goods And Services Sold	$312M
Operating Income	$61M
Selling General And Administrative	$1.2B
Research And Development	$2.6B
Operating Expenses	$3.9B
Investment Income Net	$129M
Net Interest Income	$126M
Interest Income	$129M
Interest Expense	$2.3M
Non Interest Income	$4.2B
Other Non Operating Income	$13M
Depreciation	$66M
Depreciation And Amortization	$28M
Income Before Tax	$317M
Income Tax Expense	$284M
Interest And Debt Expense	$2.3M
Net Income From Continuing Operations	$33M
Comprehensive Income Net Of Tax	$6.4M
Ebit	$61M
Ebitda	$89M
Net Income	$33M

Revenue & Profitability

Earnings Performance

INCY Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$5.4B
Total Current Assets	$3.2B
Cash And Cash Equivalents At Carrying Value	$1.7B
Cash And Short Term Investments	$1.7B
Inventory	$59M
Current Net Receivables	-
Total Non Current Assets	$2.3B
Property Plant Equipment	$763M
Accumulated Depreciation Amortization Ppe	$328M
Intangible Assets	$383M
Intangible Assets Excluding Goodwill	$228M
Goodwill	$156M
Investments	$470M
Long Term Investments	$19M
Short Term Investments	$470M
Other Current Assets	$169M
Other Non Current Assets	$11M
Total Liabilities	$2B
Total Current Liabilities	$1.6B
Current Accounts Payable	$197M
Deferred Revenue	-
Current Debt	$4.4M
Short Term Debt	$10M
Total Non Current Liabilities	$372M
Capital Lease Obligations	$34M
Long Term Debt	$34M
Current Long Term Debt	-
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$38M
Other Current Liabilities	$59M
Other Non Current Liabilities	$168M
Total Shareholder Equity	$3.4B
Treasury Stock	-
Retained Earnings	-$1.1B
Common Stock	$193K
Common Stock Shares Outstanding	$193M

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	$335M
Payments For Operating Activities	$7.1M
Proceeds From Operating Activities	-
Change In Operating Liabilities	$367M
Change In Operating Assets	$314M
Depreciation Depletion And Amortization	$89M
Capital Expenditures	$100M
Change In Receivables	$112M
Change In Inventory	$128M
Profit Loss	$33M
Cashflow From Investment	$158M
Cashflow From Financing	-$2B
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	$2B
Payments For Repurchase Of Equity	$2B
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-$2B
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$33M

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$3.9B
Total Revenue	$4.2B
Cost Of Revenue	$312M
Costof Goods And Services Sold	$312M
Operating Income	$61M
Selling General And Administrative	$1.2B
Research And Development	$2.6B
Operating Expenses	$3.9B
Investment Income Net	$129M
Net Interest Income	$126M
Interest Income	$129M
Interest Expense	$2.3M
Non Interest Income	$4.2B
Other Non Operating Income	$13M
Depreciation	$66M
Depreciation And Amortization	$28M
Income Before Tax	$317M
Income Tax Expense	$284M
Interest And Debt Expense	$2.3M
Net Income From Continuing Operations	$33M
Comprehensive Income Net Of Tax	$6.4M
Ebit	$61M
Ebitda	$89M
Net Income	$33M

INCY Profile

Incyte Corporation Profile

Sector: TRADE & SERVICES

Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH

Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.

Most Active

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	9.42%	-	776,312,724
NVDA	$101.80	-7.81%	$2.68T	338,769,412
INTC	$22.43	2.05%	$95.85B	242,972,129
F	$9.55	-5.96%	$39.53B	213,326,329
LCID	$2.32	-3.33%	$7.67B	211,931,403

See more →

Symbol	Price	Change %	Market Cap	Volume
AMZN	$178.41	-8.98%	$2.04T	95,553,617
WMT	$87.22	-2.83%	$719.59B	32,963,171
V	$339.36	-2.01%	$668.07B	8,784,245
BABA	$129.40	-0.30%	$316.95B	29,977,662
DIS	$88.84	-9.24%	$176.58B	19,076,825

See more →

Top Gainers

Symbol	Price	Change %	Market Cap	Volume
VCIG	$5.99	1,796.17%	$744.62K	310,904
MRM	$0.69	87.76%	$2.91M	54,062,078
PTIX	$0.42	84.14%	$4.04M	177,332,811
OSRH	$2.47	68.03%	$40.06M	89,499,750
OMQS	$0.06	62.16%	$1.50M	59,659

See more →

Top Losers

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	21,941,899
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
ICCT	$2.07	-56.14%	$9.78M	12,637,345